Moleculera
1 known investors
Find your way into Moleculera
Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.
Investors · 1
Frequently asked questions
- What does Moleculera do?
- Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.
- Who are Moleculera's investors?
- Moleculera's investors include Prolog Ventures.